Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,171,561
-
Share change
-
+530,319
-
Total reported value
-
$378,627,411
-
Price per share
-
$22.05
-
Number of holders
-
56
-
Value change
-
+$14,263,124
-
Number of buys
-
35
-
Number of sells
-
21
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q1 2019
As of 31 Mar 2019,
AVROBIO INC - COM (AVRO) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,171,561 shares.
The largest 10 holders included
Blackstone Group L.P., SV Health Investors, LLC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, Aisling Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, and EMERALD ADVISERS, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.